- Home
- ADMA vs UBSI Comparison
ADMA vs UBSI Comparison
Compare ADMA & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- UBSI
- Stock Information
- Founded
- ADMA 2004
- UBSI 1982
- Country
- ADMA United States
- UBSI United States
- Employees
- ADMA N/A
- UBSI N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- UBSI Major Banks
- Sector
- ADMA Health Care
- UBSI Finance
- Exchange
- ADMA Nasdaq
- UBSI Nasdaq
- Market Cap
- ADMA 5.1B
- UBSI 5.3B
- IPO Year
- ADMA N/A
- UBSI N/A
- Fundamental
- Price
- ADMA $19.83
- UBSI $35.71
- Analyst Decision
- ADMA Strong Buy
- UBSI Hold
- Analyst Count
- ADMA 4
- UBSI 4
- Target Price
- ADMA $24.25
- UBSI $40.13
- AVG Volume (30 Days)
- ADMA 3.4M
- UBSI 544.8K
- Earning Date
- ADMA 05-07-2025
- UBSI 07-24-2025
- Dividend Yield
- ADMA N/A
- UBSI 4.09%
- EPS Growth
- ADMA N/A
- UBSI 2.88
- EPS
- ADMA 0.84
- UBSI 2.70
- Revenue
- ADMA $459,381,000.00
- UBSI $1,021,155,000.00
- Revenue This Year
- ADMA $19.45
- UBSI $20.15
- Revenue Next Year
- ADMA $28.10
- UBSI $5.19
- P/E Ratio
- ADMA $23.74
- UBSI $13.41
- Revenue Growth
- ADMA 62.23
- UBSI 0.82
- 52 Week Low
- ADMA $9.40
- UBSI $30.51
- 52 Week High
- ADMA $25.67
- UBSI $44.43
- Technical
- Relative Strength Index (RSI)
- ADMA 46.14
- UBSI 47.95
- Support Level
- ADMA $19.28
- UBSI $35.95
- Resistance Level
- ADMA $20.14
- UBSI $36.88
- Average True Range (ATR)
- ADMA 0.74
- UBSI 0.63
- MACD
- ADMA -0.09
- UBSI -0.18
- Stochastic Oscillator
- ADMA 55.14
- UBSI 8.33
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.